Published in J Immunol on March 01, 2002
Eotaxin-3 and a uniquely conserved gene-expression profile in eosinophilic esophagitis. J Clin Invest (2006) 5.48
Thymic stromal lymphopoietin-elicited basophil responses promote eosinophilic esophagitis. Nat Med (2013) 2.94
Biology and treatment of eosinophilic esophagitis. Gastroenterology (2009) 2.18
Food allergy testing in eosinophilic esophagitis: what the gastroenterologist needs to know. Clin Gastroenterol Hepatol (2013) 2.17
TGFβ receptor mutations impose a strong predisposition for human allergic disease. Sci Transl Med (2013) 2.08
Anti-IL-5 (mepolizumab) therapy reduces eosinophil activation ex vivo and increases IL-5 and IL-5 receptor levels. J Allergy Clin Immunol (2008) 2.04
Involvement of mast cells in eosinophilic esophagitis. J Allergy Clin Immunol (2010) 1.92
A striking local esophageal cytokine expression profile in eosinophilic esophagitis. J Allergy Clin Immunol (2011) 1.82
Eosinophil infiltration and degranulation in oesophageal mucosa from adult patients with eosinophilic oesophagitis: a retrospective and comparative study on pathological biopsy. J Clin Pathol (2006) 1.75
Biology of the eosinophil. Adv Immunol (2009) 1.74
Esophageal remodeling develops as a consequence of tissue specific IL-5-induced eosinophilia. Gastroenterology (2007) 1.71
Markers of antigen presentation and activation on eosinophils and T cells in the esophageal tissue of patients with eosinophilic esophagitis. J Pediatr Gastroenterol Nutr (2013) 1.49
Basic pathogenesis of eosinophilic esophagitis. Gastrointest Endosc Clin N Am (2008) 1.45
Eosinophilic esophagitis. Dig Dis Sci (2009) 1.43
Organ-specific eosinophilic disorders of the skin, lung, and gastrointestinal tract. J Allergy Clin Immunol (2010) 1.25
Eosinophilic esophagitis: strictures, impactions, dysphagia. Dig Dis Sci (2003) 1.17
A Japanese case of eosinophilic esophagitis. J Gastroenterol (2006) 1.13
Molecular, genetic, and cellular bases for treating eosinophilic esophagitis. Gastroenterology (2015) 1.11
De-novo onset of eosinophilic esophagitis after large volume allergen exposures. J Gastrointestin Liver Dis (2013) 1.10
Significance of para-esophageal lymph nodes in food or aeroallergen-induced iNKT cell-mediated experimental eosinophilic esophagitis. Am J Physiol Gastrointest Liver Physiol (2011) 1.09
Esophageal functional impairments in experimental eosinophilic esophagitis. Am J Physiol Gastrointest Liver Physiol (2012) 1.09
Allergy and eosinophil-associated gastrointestinal disorders (EGID). Curr Opin Immunol (2008) 1.09
Eosinophilic esophagitis: the newest esophageal inflammatory disease. Nat Rev Gastroenterol Hepatol (2009) 1.09
Interleukin-15 expression is increased in human eosinophilic esophagitis and mediates pathogenesis in mice. Gastroenterology (2010) 1.08
Anti-IL-5 therapy reduces mast cell and IL-9 cell numbers in pediatric patients with eosinophilic esophagitis. J Allergy Clin Immunol (2013) 1.08
Allergic mechanisms in eosinophilic esophagitis. Gastroenterol Clin North Am (2014) 1.08
Allergen-specific in vitro cytokine production in adult patients with eosinophilic esophagitis. Dig Dis Sci (2006) 1.07
An imbalance of esophageal effector and regulatory T cell subsets in experimental eosinophilic esophagitis in mice. Am J Physiol Gastrointest Liver Physiol (2009) 1.05
Pathogenic role of mast cells in experimental eosinophilic esophagitis. Am J Physiol Gastrointest Liver Physiol (2013) 0.98
The FIP1L1-PDGFRA fusion gene cooperates with IL-5 to induce murine hypereosinophilic syndrome (HES)/chronic eosinophilic leukemia (CEL)-like disease. Blood (2006) 0.97
The ubiquitin ligase adaptor Ndfip1 regulates T cell-mediated gastrointestinal inflammation and inflammatory bowel disease susceptibility. Mucosal Immunol (2010) 0.97
Eosinophils in mucosal immune responses. Mucosal Immunol (2015) 0.97
Indoor insect allergens are potent inducers of experimental eosinophilic esophagitis in mice. J Leukoc Biol (2010) 0.96
Comparative analysis of FcεRI expression patterns in patients with eosinophilic and reflux esophagitis. J Pediatr Gastroenterol Nutr (2010) 0.95
Mechanism of eosinophilic esophagitis. Immunol Allergy Clin North Am (2009) 0.93
Epicutaneous immunotherapy (EPIT) blocks the allergic esophago-gastro-enteropathy induced by sustained oral exposure to peanuts in sensitized mice. PLoS One (2012) 0.92
Ultrastructural features of eosinophilic oesophagitis: impact of treatment on desmosomes. J Clin Pathol (2014) 0.89
Immunomodulatory therapy of eosinophil-associated gastrointestinal diseases. Clin Exp Allergy (2008) 0.89
Interleukin-13 directly promotes oesophagus production of CCL11 and CCL24 and the migration of eosinophils. Clin Exp Allergy (2009) 0.88
Eosinophilic esophagitis: perspectives of adult and pediatric gastroenterologists. Dig Dis Sci (2009) 0.88
Pathogenesis of allergen-induced eosinophilic esophagitis is independent of interleukin (IL)-13. Immunol Cell Biol (2013) 0.88
Eosinophils in Gastrointestinal Disorders: Eosinophilic Gastrointestinal Diseases, Celiac Disease, Inflammatory Bowel Diseases, and Parasitic Infections. Immunol Allergy Clin North Am (2015) 0.87
Invariant natural killer T-cell neutralization is a possible novel therapy for human eosinophilic esophagitis. Clin Transl Immunology (2014) 0.85
Recent advances in the treatment of eosinophilic esophagitis. Expert Rev Clin Immunol (2010) 0.85
Eosinophilic gastrointestinal diseases: review and update. ISRN Gastroenterol (2012) 0.84
Eosinophilic esophagitis: historical perspective on an evolving disease. Gastroenterol Clin North Am (2014) 0.84
Eosinophilic gastrointestinal diseases--clinically diverse and histopathologically confounding. Semin Immunopathol (2012) 0.84
Allergen-induced resistin-like molecule-α promotes esophageal epithelial cell hyperplasia in eosinophilic esophagitis. Am J Physiol Gastrointest Liver Physiol (2014) 0.81
Mechanisms of Disease of Eosinophilic Esophagitis. Annu Rev Pathol (2016) 0.81
Involvement of interleukin-18 in the pathogenesis of human eosinophilic esophagitis. Clin Immunol (2015) 0.80
International survey on evaluation and management of eosinophilic esophagitis. World Allergy Organ J (2012) 0.80
Misregulation of suppressors of cytokine signaling in eosinophilic esophagitis. J Gastroenterol (2012) 0.80
Eosinophilic esophagitis: which role for food and inhalant allergens? Asia Pac Allergy (2012) 0.80
Allergic mechanisms of Eosinophilic oesophagitis. Best Pract Res Clin Gastroenterol (2015) 0.79
Preferential Secretion of Thymic Stromal Lymphopoietin (TSLP) by Terminally Differentiated Esophageal Epithelial Cells: Relevance to Eosinophilic Esophagitis (EoE). PLoS One (2016) 0.78
Diagnostic and therapeutic strategies for eosinophilic esophagitis. Clin Pract (Lond) (2014) 0.78
Immunophenotyping of peripheral eosinophils demonstrates activation in eosinophilic esophagitis. J Pediatr Gastroenterol Nutr (2011) 0.78
The Immunologic Mechanisms of Eosinophilic Esophagitis. Curr Allergy Asthma Rep (2016) 0.77
Expanding the paradigm of eosinophilic esophagitis: mast cells and IL-9. J Allergy Clin Immunol (2013) 0.77
The pathophysiology of eosinophilic esophagitis. Front Pediatr (2014) 0.77
Macrophage migration inhibitory factor promotes eosinophil accumulation and tissue remodeling in eosinophilic esophagitis. Mucosal Immunol (2015) 0.77
An overview of eosinophilic esophagitis. Gut Liver (2014) 0.77
Immunotherapeutic approaches for the treatment of eosinophilic esophagitis. Immunotherapy (2014) 0.77
Eosinophilic esophagitis: New insights in pathogenesis and therapy. World J Gastrointest Pharmacol Ther (2016) 0.76
Significance of Mouse Models in Dissecting the Mechanism of Human Eosinophilic Gastrointestinal Diseases (EGID). J Gastroenterol Hepatol Res (2015) 0.76
Allergen-induced interleukin-18 promotes experimental eosinophilic oesophagitis in mice. Immunol Cell Biol (2015) 0.76
Translating new developments in eosinophilic esophagitis pathogenesis into clinical practice. Curr Treat Options Gastroenterol (2015) 0.76
Elements Involved In Promoting Eosinophilic Gastrointestinal Disorders. J Genet Syndr Gene Ther (2015) 0.76
Characterizing the inflammatory response in esophageal mucosal biopsies in children with eosinophilic esophagitis. Clin Transl Immunology (2016) 0.75
Eosinophilic Esophagitis: Current Aspects of a Recently Recognized Disease. Gastroenterology Res (2010) 0.75
Do We Know What Causes Eosinophilic Esophagitis? A Mechanistic Update. Curr Gastroenterol Rep (2015) 0.75
Current hurdles in the management of eosinophilic oesophagitis: the next steps. World J Gastroenterol (2013) 0.75
Role of food and aeroallergen sensitization in eosinophilic esophagitis in adults. Ann Allergy Asthma Immunol (2016) 0.75
From genetics to treatment of eosinophilic esophagitis. Curr Opin Allergy Clin Immunol (2015) 0.75
Recent discoveries and emerging therapeutics in eosinophilic esophagitis. World J Gastrointest Pharmacol Ther (2016) 0.75
Microbiome and its impact on gastrointestinal atopy. Allergy (2016) 0.75
Eosinophilic Esophagitis: update on treatment approaches. Hippokratia (2012) 0.75
Chemotactic factors associated with eosinophilic gastrointestinal diseases. Immunol Allergy Clin North Am (2009) 0.75
TNF-related apoptosis-inducing ligand (TRAIL) regulates midline-1, thymic stromal lymphopoietin, inflammation, and remodeling in experimental eosinophilic esophagitis. J Allergy Clin Immunol (2015) 0.75
Role of mucosal inflammation in eosinophilic esophagitis: review of the literature. ISRN Gastroenterol (2010) 0.75
Eosinophilic Esophagitis in Children. Curr Allergy Asthma Rep (2017) 0.75
Eosinophilic esophagitis: updated consensus recommendations for children and adults. J Allergy Clin Immunol (2011) 12.48
Eosinophilic esophagitis in children and adults: a systematic review and consensus recommendations for diagnosis and treatment. Gastroenterology (2007) 9.05
The eosinophil. Annu Rev Immunol (2006) 7.06
Eotaxin-3 and a uniquely conserved gene-expression profile in eosinophilic esophagitis. J Clin Invest (2006) 5.48
Eosinophilic esophagitis. N Engl J Med (2004) 4.43
Dissection of experimental asthma with DNA microarray analysis identifies arginase in asthma pathogenesis. J Clin Invest (2003) 4.08
Eosinophils: biological properties and role in health and disease. Clin Exp Allergy (2008) 3.92
Hypereosinophilic syndrome: a multicenter, retrospective analysis of clinical characteristics and response to therapy. J Allergy Clin Immunol (2009) 3.74
A randomized, double-blind, placebo-controlled trial of fluticasone propionate for pediatric eosinophilic esophagitis. Gastroenterology (2006) 3.68
Anti-IL-5 (mepolizumab) therapy for eosinophilic esophagitis. J Allergy Clin Immunol (2006) 3.51
Comparative dietary therapy effectiveness in remission of pediatric eosinophilic esophagitis. J Allergy Clin Immunol (2012) 3.45
IL-13 involvement in eosinophilic esophagitis: transcriptome analysis and reversibility with glucocorticoids. J Allergy Clin Immunol (2007) 3.24
Approaches to the treatment of hypereosinophilic syndromes: a workshop summary report. J Allergy Clin Immunol (2006) 3.04
MicroRNA-21 is up-regulated in allergic airway inflammation and regulates IL-12p35 expression. J Immunol (2009) 2.89
Refining the definition of hypereosinophilic syndrome. J Allergy Clin Immunol (2010) 2.74
Intestinal barrier function: molecular regulation and disease pathogenesis. J Allergy Clin Immunol (2009) 2.63
Intratracheal IL-13 induces eosinophilic esophagitis by an IL-5, eotaxin-1, and STAT6-dependent mechanism. Gastroenterology (2003) 2.40
CCR3 is a target for age-related macular degeneration diagnosis and therapy. Nature (2009) 2.39
Foxa2 regulates alveolarization and goblet cell hyperplasia. Development (2004) 2.35
Anti-interleukin-5 (mepolizumab) therapy for hypereosinophilic syndromes. J Allergy Clin Immunol (2003) 2.31
IL-9- and mast cell-mediated intestinal permeability predisposes to oral antigen hypersensitivity. J Exp Med (2008) 2.19
Pediatric patients with eosinophilic esophagitis: an 8-year follow-up. J Allergy Clin Immunol (2007) 2.18
Mast cells are required for experimental oral allergen-induced diarrhea. J Clin Invest (2003) 2.17
Clinical, pathologic, and molecular characterization of familial eosinophilic esophagitis compared with sporadic cases. Clin Gastroenterol Hepatol (2008) 2.12
Chemokines in asthma: cooperative interaction between chemokines and IL-13. J Allergy Clin Immunol (2003) 2.06
Anti-IL-5 (mepolizumab) therapy reduces eosinophil activation ex vivo and increases IL-5 and IL-5 receptor levels. J Allergy Clin Immunol (2008) 2.04
Intrinsic defect in T cell production of interleukin (IL)-13 in the absence of both IL-5 and eotaxin precludes the development of eosinophilia and airways hyperreactivity in experimental asthma. J Exp Med (2002) 2.04
Identification, epidemiology, and chronicity of pediatric esophageal eosinophilia, 1982-1999. J Allergy Clin Immunol (2010) 2.00
MicroRNA-21 limits in vivo immune response-mediated activation of the IL-12/IFN-gamma pathway, Th1 polarization, and the severity of delayed-type hypersensitivity. J Immunol (2011) 2.00
Intestinal epithelial cell secretion of RELM-beta protects against gastrointestinal worm infection. J Exp Med (2009) 1.97
Involvement of mast cells in eosinophilic esophagitis. J Allergy Clin Immunol (2010) 1.92
Clinical and immunopathologic effects of swallowed fluticasone for eosinophilic esophagitis. Clin Gastroenterol Hepatol (2004) 1.87
Importance of cytokines in murine allergic airway disease and human asthma. J Immunol (2010) 1.86
Coordinate interaction between IL-13 and epithelial differentiation cluster genes in eosinophilic esophagitis. J Immunol (2010) 1.85
Resistin-like molecule-beta is an allergen-induced cytokine with inflammatory and remodeling activity in the murine lung. Am J Physiol Lung Cell Mol Physiol (2007) 1.85
Potential of blood eosinophils, eosinophil-derived neurotoxin, and eotaxin-3 as biomarkers of eosinophilic esophagitis. Clin Gastroenterol Hepatol (2006) 1.84
A striking local esophageal cytokine expression profile in eosinophilic esophagitis. J Allergy Clin Immunol (2011) 1.82
Reslizumab in children and adolescents with eosinophilic esophagitis: results of a double-blind, randomized, placebo-controlled trial. J Allergy Clin Immunol (2011) 1.82
Molecular mechanisms of anaphylaxis: lessons from studies with murine models. J Allergy Clin Immunol (2005) 1.80
MicroRNA signature in patients with eosinophilic esophagitis, reversibility with glucocorticoids, and assessment as disease biomarkers. J Allergy Clin Immunol (2012) 1.79
Resistin-like molecule beta regulates innate colonic function: barrier integrity and inflammation susceptibility. J Allergy Clin Immunol (2006) 1.79
Epicutaneous antigen exposure primes for experimental eosinophilic esophagitis in mice. Gastroenterology (2005) 1.78
Prevalence and outcome of allergic colitis in healthy infants with rectal bleeding: a prospective cohort study. J Pediatr Gastroenterol Nutr (2005) 1.78
Biology of the eosinophil. Adv Immunol (2009) 1.74
Variants of thymic stromal lymphopoietin and its receptor associate with eosinophilic esophagitis. J Allergy Clin Immunol (2010) 1.74
The eotaxin chemokines and CCR3 are fundamental regulators of allergen-induced pulmonary eosinophilia. J Immunol (2005) 1.73
Esophageal remodeling develops as a consequence of tissue specific IL-5-induced eosinophilia. Gastroenterology (2007) 1.71
Arginase I suppresses IL-12/IL-23p40-driven intestinal inflammation during acute schistosomiasis. J Immunol (2010) 1.67
Glucocorticoid-regulated genes in eosinophilic esophagitis: a role for FKBP51. J Allergy Clin Immunol (2010) 1.63
Immunopathogenesis of experimental ulcerative colitis is mediated by eosinophil peroxidase. J Immunol (2004) 1.62
MiR-223 deficiency increases eosinophil progenitor proliferation. J Immunol (2013) 1.60
Eosinophilic esophagitis: pathogenesis, genetics, and therapy. J Allergy Clin Immunol (2006) 1.60
A negative, double-blind, placebo-controlled challenge to genetically modified corn. J Allergy Clin Immunol (2003) 1.57
Critical role for adaptive T cell immunity in experimental eosinophilic esophagitis in mice. J Leukoc Biol (2006) 1.56
A central regulatory role for eosinophils and the eotaxin/CCR3 axis in chronic experimental allergic airway inflammation. Proc Natl Acad Sci U S A (2006) 1.55
Transcript signatures in experimental asthma: identification of STAT6-dependent and -independent pathways. J Immunol (2004) 1.54
Defective T cell development and function in calcineurin A beta -deficient mice. Proc Natl Acad Sci U S A (2002) 1.53
FIP1L1/PDGFRalpha synergizes with SCF to induce systemic mastocytosis in a murine model of chronic eosinophilic leukemia/hypereosinophilic syndrome. Blood (2008) 1.53
Identification of a cooperative mechanism involving interleukin-13 and eotaxin-2 in experimental allergic lung inflammation. J Biol Chem (2005) 1.52
Molecular diagnosis of eosinophilic esophagitis by gene expression profiling. Gastroenterology (2013) 1.51
Persistent effects induced by IL-13 in the lung. Am J Respir Cell Mol Biol (2006) 1.47
Targeting eosinophils in allergy, inflammation and beyond. Nat Rev Drug Discov (2013) 1.47
Basic pathogenesis of eosinophilic esophagitis. Gastrointest Endosc Clin N Am (2008) 1.45
Dissociation between symptoms and histological severity in pediatric eosinophilic esophagitis. J Pediatr Gastroenterol Nutr (2009) 1.44
Quantity and distribution of eosinophils in the gastrointestinal tract of children. Pediatr Dev Pathol (2006) 1.44
IL-13 induces esophageal remodeling and gene expression by an eosinophil-independent, IL-13R alpha 2-inhibited pathway. J Immunol (2010) 1.41
Modulatory calcineurin-interacting proteins 1 and 2 function as calcineurin facilitators in vivo. Proc Natl Acad Sci U S A (2006) 1.40
Inhibition of arginase I activity by RNA interference attenuates IL-13-induced airways hyperresponsiveness. J Immunol (2006) 1.40
Crosstalk between Gi and Gq/Gs pathways in airway smooth muscle regulates bronchial contractility and relaxation. J Clin Invest (2007) 1.40
Pulmonary chemokine expression is coordinately regulated by STAT1, STAT6, and IFN-gamma. J Immunol (2004) 1.38
IL-17E upregulates the expression of proinflammatory cytokines in lung fibroblasts. J Allergy Clin Immunol (2006) 1.37
Regulation of carcinogenesis by IL-5 and CCL11: a potential role for eosinophils in tumor immune surveillance. J Immunol (2007) 1.36
High prevalence of eosinophilic esophagitis in patients with inherited connective tissue disorders. J Allergy Clin Immunol (2013) 1.35
Mast cells regulate homeostatic intestinal epithelial migration and barrier function by a chymase/Mcpt4-dependent mechanism. Proc Natl Acad Sci U S A (2009) 1.34
Intestinal macrophage/epithelial cell-derived CCL11/eotaxin-1 mediates eosinophil recruitment and function in pediatric ulcerative colitis. J Immunol (2008) 1.33
Colonic eosinophilic inflammation in experimental colitis is mediated by Ly6C(high) CCR2(+) inflammatory monocyte/macrophage-derived CCL11. J Immunol (2011) 1.33
Resistin-like molecule alpha enhances myeloid cell activation and promotes colitis. J Allergy Clin Immunol (2008) 1.32
Health-related quality of life across pediatric chronic conditions. J Pediatr (2010) 1.29
Immunotherapy of cytotoxic T cell-resistant tumors by T helper 2 cells: an eotaxin and STAT6-dependent process. J Exp Med (2003) 1.28
Interplay of adaptive th2 immunity with eotaxin-3/c-C chemokine receptor 3 in eosinophilic esophagitis. J Pediatr Gastroenterol Nutr (2007) 1.26
A dual activation and inhibition role for the paired immunoglobulin-like receptor B in eosinophils. Blood (2008) 1.26
Organ-specific eosinophilic disorders of the skin, lung, and gastrointestinal tract. J Allergy Clin Immunol (2010) 1.25
Eosinophils and CCR3 regulate interleukin-13 transgene-induced pulmonary remodeling. Am J Pathol (2006) 1.25